Organon & Co. (1OGN)
MTA
Closed
Oct 2, 2026
Day's Range
12.1452 wk Range
4.86Profile - 1OGN - Organon & Co.
Profile
Mic Code
XMIL
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
10K
Organon & Co. is a global pharmaceutical company focused on women’s health, biosimilars, and established prescription medicines. Organon & Co. develops and delivers health solutions across a broad portfolio that includes therapies and medical devices used in reproductive health, contraception, fertility, dermatology, cardiovascular care, respiratory conditions, and other areas of general medicine. The company serves patients and healthcare providers in more than 140 markets through wholesalers, retailers, hospitals, government agencies, and managed care organizations. Its women’s health business is a central part of the portfolio, supported by biosimilars and well-known legacy brands that address everyday treatment needs across multiple therapeutic areas. Organon & Co. operates as a diversified healthcare provider with a strong international footprint and a product mix designed to meet ongoing demand for prescription treatments and essential medicines.
Profile Details
Type
Common Stock
Address
30 Hudson Street
City
Jersey City
State
NJ
Zip
07302
Country
United States
Phone
551 430 6900
Key Executives - 1OGN - Organon & Co.
Key executives
Cross Listings - 1OGN - Organon & Co.
Also listed on
The same company trading on other exchanges.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
